Drawing for CELLULAR LIFT REGENERATION (CLR)

USPTO serial 79429030

CELLULAR LIFT REGENERATION (CLR)

Reviewed by CopyMark Law Group

Reg. 8407650Status 700Registered
Filing date
Status date
Registration date
Aug 25, 2026
Examiner
HUDSON, TAMARA BREE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLULAR LIFT REGENERATION (CLR)?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and veterinary preparations, in particular for the prevention and treatment of cartilage and bone diseases; chemicals for medical purposes, in particular for the prevention and treatment of cartilage and bone diseases; biological preparations for use in cell cultures for medical purposes; medicines for use in human and veterinary medicine for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; drug delivery agents in the form of tablets, capsules, pastilles, and granules that facilitate the delivery of pharmaceutical preparations; ointments for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; injection solutions for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; dietetic foods and beverages adapted for use in human and veterinary medicine; therapeutic food for dietetic medical purposes; medicinal drinks; dietary supplements, in particular for medical purposes; vitamin and multi-vitamin preparations, in particular for medical purposes; mineral supplements and mineral preparations, in particular for medical purposes; biological and chemical preparations for medical diagnostic purposes for use in laboratories, pharmacies and doctors' surgeries; chemical test preparations for medical diagnostic purposes, in particular reagents, standard solutions, biological indicators and cell culture media; pre-filled syringes sold filled with cell growth factors, analgesics, hyaluronic acid and its derivates, vitamins and mineralsACTIVE
010Surgical apparatus and instruments; medical and dental apparatus and instruments, namely, arthroscopic trocar, arthroscopic working sleeves, arthroscopic drills and arthroscopic plungers; vials sold empty for the purpose of medical infusions; medical analytical apparatus, namely, X-ray apparatus, computed tomography apparatus, magnetic resonance imaging apparatus and arthroscopes; implants consisting of artificial materials for use in human and veterinary medicine, in particular for the prevention and treatment of cartilage and bone diseasesACTIVE
016Printed matter, namely brochures for patients and magazines with advertising, including for pharmacies and doctors, all the aforesaid relating to the prevention and treatment of cartilage and bone diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 25, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 7, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 11, 2026XAECEXAMINER'S AMENDMENT ENTERED
Jun 11, 2026GNEAEXAMINERS AMENDMENT E-MAILED
Jun 11, 2026CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 10, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 25, 2025RFNTREFUSAL PROCESSED BY IB
Dec 10, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 10, 2025RFRRREFUSAL PROCESSED BY MPU
Nov 1, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 31, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2025DOCKASSIGNED TO EXAMINER
Sep 5, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 1, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Aug 1, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance